...
首页> 外文期刊>Human Genetics >Low beta-glucuronidase enzyme activity and mutations in the human beta-glucuronidase gene in mild mucopolysaccharidosis type VII, pseudodeficiency and a heterozygote.
【24h】

Low beta-glucuronidase enzyme activity and mutations in the human beta-glucuronidase gene in mild mucopolysaccharidosis type VII, pseudodeficiency and a heterozygote.

机译:低度β-葡萄糖醛酸酶活性和人类VII型黏多糖贮积病,假性缺陷和杂合子中人类β-葡萄糖醛酸酶基因中的突变。

获取原文
获取原文并翻译 | 示例
           

摘要

Deficiency of beta-glucuronidase is the cause of the human lysosomal storage disorder mucopolysaccharidosis type VII (MPS VII). The wide interfamilial variation in the presentation of this disorder complicates clinical diagnosis. Since greatly reduced beta-glucuronidase enzyme activity may also be found in healthy individuals (pseudodeficiency), diagnosis based on the biochemical phenotype is also difficult. This is illustrated by the patients studied here, who had extremely mild symptoms confined to the spine, or tachycardia, or upper respiratory infection, and who had low beta-glucuronidase activity, and excessive granulation of granulocytes and monocytes on routine blood smears. Low enzyme activity was caused by mutations in the beta-glucuronidase gene in all cases. One patient was homozygous for the previously described D152N allele. Family information and 35SO4-uptake studies clearly demonstrated that he was pseudodeficient, with symptoms unrelated to his low beta-glucuronidase activity. Two patients of another family were compound heterozygotes for a C38G and a Y626H allele, and were probably extremely mild MPS VII patients. The low beta-glucuronidase activity in another mild MPS VII patient was due to reduced biosynthesis of stable mRNA from one allele, and a W446X mutation on the second. Extremely low beta-glucuronidase enzyme activity was also found in the serum of a carrier of a 1801deltaT allele, possibly as a consequence of a dominant-negative effect. A combination of investigations is necessary in order to differentiate between mild disease and pseudodeficiency in individuals with enzyme activities close to the threshold.
机译:β-葡糖醛酸糖苷酶的缺乏是人类溶酶体贮积病VII型粘多糖贮积病(MPS VII)的原因。该疾病表现的广泛的家族间变异使临床诊断变得复杂。由于在健康个体中也可能发现β-葡萄糖醛酸苷酶的活性大大降低(假缺陷),因此基于生化表型的诊断也很困难。此处研究的患者证明了这一点,这些患者的症状仅限于脊柱或心动过速或上呼吸道感染,并且β-葡萄糖醛酸苷酶活性低,常规涂片检查中的粒细胞和单核细胞过度颗粒化。在所有情况下,酶活性低均由β-葡萄糖醛酸苷酶基因突变引起。一名患者是先前描述的D152N等位基因纯合子。家庭信息和35SO4摄取研究清楚地表明他是假性缺陷,其症状与他的低β-葡萄糖醛酸苷酶活性无关。另一个家庭的两名患者是C38G和Y626H等位基因的复合杂合子,可能是极轻度的MPS VII患者。另一位轻度MPS VII患者的低β-葡萄糖醛酸苷酶活性是由于一个等位基因的稳定mRNA的生物合成减少,第二个等位基因出现W446X突变。在1801deltaT等位基因载体的血清中也发现极低的β-葡萄糖醛酸苷酶活性,这可能是显性负效应的结果。为了区分酶活性接近阈值的个体的轻度疾病和假性缺乏,有必要进行一系列研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号